Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;104(4):497-503.
doi: 10.1016/j.rmed.2009.11.005. Epub 2009 Nov 28.

Rhinitis in subjects with work-exacerbated asthma

Affiliations
Free article

Rhinitis in subjects with work-exacerbated asthma

Olivier Vandenplas et al. Respir Med. 2010 Apr.
Free article

Abstract

Objectives: This study aimed at characterizing the nature, severity, and timing of nasal and ocular symptoms in subjects with work-exacerbated asthma (WEA).

Methods: Among the 363 subjects referred to a tertiary-care hospital for the investigation of work-related asthma symptoms, 105 subjects who demonstrated non-specific bronchial hyperresponsiveness to histamine, but a negative response to a specific inhalation challenge with the suspected occupational agent(s) were considered as having WEA. Their characteristics were compared with those of 172 subjects with occupational asthma (OA), ascertained by a positive response to a specific inhalation challenge.

Results: A high proportion of subjects with WEA (83%) and OA (90%) reported at least one nasal symptom at work. Sneezing/itching and rhinorrhea were more frequent in subjects with OA (78% and 70%, respectively) than in those with WEA (61%, p = 0.004 and 57%, p = 0.038, respectively), while post-nasal discharge was more common in WEA (30%) than in OA (18%, p = 0.019). Nasal symptoms were less severe in WEA (median [25th-75th percentiles] global severity score: 4 [2-6]) as compared to OA (5 [4-7], p < 0.001). Nasal symptoms preceded less frequently those of asthma in subjects with WEA (17%) than in subjects with OA (43%, p = 0.001).

Conclusions: Nasal symptoms are highly prevalent in subjects with WEA, although their clinical pattern differs from that found in OA. Further investigations of the health and socio-economic impacts of upper airways symptoms in WEA are required to improve the understanding and management of this common condition.

PubMed Disclaimer

Similar articles

Cited by

  • Occupational rhinitis: an update.
    Stevens WW, Grammer LC 3rd. Stevens WW, et al. Curr Allergy Asthma Rep. 2015 Jan;15(1):487. doi: 10.1007/s11882-014-0487-8. Curr Allergy Asthma Rep. 2015. PMID: 25430949 Review.
  • Asthma and rhinitis in the workplace.
    Vandenplas O. Vandenplas O. Curr Allergy Asthma Rep. 2010 Sep;10(5):373-80. doi: 10.1007/s11882-010-0122-2. Curr Allergy Asthma Rep. 2010. PMID: 20461478 Review.
  • Occupational asthma: etiologies and risk factors.
    Vandenplas O. Vandenplas O. Allergy Asthma Immunol Res. 2011 Jul;3(3):157-67. doi: 10.4168/aair.2011.3.3.157. Epub 2011 May 20. Allergy Asthma Immunol Res. 2011. PMID: 21738881 Free PMC article.
  • Occupational asthma and occupational rhinitis: the united airways disease model revisited.
    Ameille J, Hamelin K, Andujar P, Bensefa-Colas L, Bonneterre V, Dupas D, Garnier R, Loddé BA, Rinaldo M, Descatha A, Lasfargues G, Pairon JC; members of the rnv3p. Ameille J, et al. Occup Environ Med. 2013 Jul;70(7):471-5. doi: 10.1136/oemed-2012-101048. Epub 2013 Feb 6. Occup Environ Med. 2013. PMID: 23390199 Free PMC article.
  • CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report.
    Bousquet J, Onorato GL, Bachert C, Barbolini M, Bedbrook A, Bjermer L, de Sousa JC, Chavannes NH, Cruz AA, De Manuel Keenoy E, Devillier P, Fonseca J, Hun S, Kostka T, Hellings PW, Illario M, Ivancevich JC, Larenas-Linnemann D, Millot-Keurinck J, Ryan D, Samolinski B, Sheikh A, Yorgancioglu A, Agache I, Arnavielhe S, Bewick M, Annesi-Maesano I, Anto JM, Bergmann KC, Bindslev-Jensen C, Bosnic-Anticevich S, Bouchard J, Caimmi DP, Camargos P, Canonica GW, Cardona V, Carriazo AM, Cingi C, Colgan E, Custovic A, Dahl R, Demoly P, De Vries G, Fokkens WJ, Fontaine JF, Gemicioğlu B, Guldemond N, Gutter Z, Haahtela T, Hellqvist-Dahl B, Jares E, Joos G, Just J, Khaltaev N, Keil T, Klimek L, Kowalski ML, Kull I, Kuna P, Kvedariene V, Laune D, Louis R, Magnan A, Malva J, Mathieu-Dupas E, Melén E, Menditto E, Morais-Almeida M, Mösges R, Mullol J, Murray R, Neffen H, O'Hehir R, Palkonen S, Papadopoulos NG, Passalacqua G, Pépin JL, Portejoie F, Price D, Pugin B, Raciborski F, Simons FER, Sova M, Spranger O, Stellato C, Todo Bom A, Tomazic PV, Triggiani M, Valero A, Valovirta E, VandenPlas O, Valiulis A, van Eerd M, Ventura MT, Wickman M, Young I, Zuberbier T, Zurkuhlen A, Senn A. Bousquet J, et al. Clin Transl Allergy. 2017 Oct 23;7:37. doi: 10.1186/s13601-017-0173-8. eCollection 2017. Clin Transl Allergy. 2017. PMID: 29075437 Free PMC article. Review.

Publication types

MeSH terms